Patients Realising the vision of value-based healthcare in cataract s... Value-based healthcare (VBHC) is gaining traction across the industry for its potential to improve patient care by standardising clinical and patient outcomes.
News Summit climbs on rumour of $15bn AstraZeneca interest Is AstraZeneca about to join the ranks of pharma companies spending big bucks on PD(L)-1xVEGF bispecific antibodies for cancer?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face